Cargando…
Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus Risks
The burden of multiple sclerosis (MS) in women of childbearing potential is increasing, with peak incidence around the age of 30 years, increasing incidence and prevalence, and growing female : male ratio. Guidelines recommend early use of disease-modifying therapies (DMTs), which are contraindicate...
Autores principales: | Alroughani, Raed, Altintas, Ayse, Al Jumah, Mohammed, Sahraian, Mohammadali, Alsharoqi, Issa, AlTahan, Abdurahman, Daif, Abdulkader, Dahdaleh, Maurice, Deleu, Dirk, Fernandez, Oscar, Grigoriadis, Nikolaos, Inshasi, Jihad, Karabudak, Rana, Taha, Karim, Totolyan, Natalia, Yamout, Bassem I., Zakaria, Magd, Bohlega, Saeed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203912/ https://www.ncbi.nlm.nih.gov/pubmed/28078140 http://dx.doi.org/10.1155/2016/1034912 |
Ejemplares similares
-
Future of Management of Multiple Sclerosis in the Middle East: A Consensus View from Specialists in Ten Countries
por: Aljumah, Mohammed, et al.
Publicado: (2013) -
MENACTRIMS practice guideline for COVID-19 vaccination in patients with multiple sclerosis
por: Yamout, Bassem I, et al.
Publicado: (2021) -
Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoring
por: Alroughani, Raed A, et al.
Publicado: (2014) -
Immune Reconstitution Therapy or Continuous Immunosuppression for the Management of Active Relapsing–Remitting Multiple Sclerosis Patients? A Narrative Review
por: AlSharoqi, Isa Ahmed, et al.
Publicado: (2020) -
A Prospective Multicenter Study for Assessing MusiQoL Validity among Arabic-Speaking MS Patients Treated with Subcutaneous Interferon β-1a
por: Al Jumah, Mohammed, et al.
Publicado: (2021)